SBI-0206965
|
|
- CAS番号.
- 1884220-36-3
- 化学名:
- 别名:
- 英語名:
- SBI-0206965
- 英語别名:
- CS-1581;SBI-0206965;SBI-0206965(02);SBI 0206965;SBI0206965;SBI0206965; SBI-0206965; SBI 0206965.;2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide;SBI-0206965,SBI 0206965,inhibit,Inhibitor,Unc-51 like kinase,Apoptosis,Autophagy,ULK;Benzamide, 2-[[5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]oxy]-N-methyl-
- CBNumber:
- CB83039306
- 化学式:
- C21H21BrN4O5
- 分子量:
- 489.32
- MOL File:
- 1884220-36-3.mol
|
SBI-0206965 物理性質
- 融点 :
- 170 - 172°C
- 比重(密度) :
- 1.434±0.06 g/cm3(Predicted)
- 貯蔵温度 :
- -20°C
- 溶解性:
- DMSO に可溶 (最大 30 mg/ml)
- 酸解離定数(Pka):
- 14.80±0.46(Predicted)
- 外見 :
- 粉
- 色:
- 白からベージュ
- 安定性::
- -20°C の DMSO 溶液で最大 3 か月間保存できます。
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
SBI-0206965 価格
もっと(4)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQV-1628 |
Sbi-0206965 |
1884220-36-3 |
250mg |
¥75000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01COBQV-1628 |
Sbi-0206965 |
1884220-36-3 |
1g |
¥927000 |
2023-06-01 |
購入 |
Sigma-Aldrich Japan
|
SML1540 |
≥98% (HPLC)
SBI-0206965 ≥98% (HPLC) |
1884220-36-3 |
5mg |
¥33700 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
SML1540 |
≥98% (HPLC)
SBI-0206965 ≥98% (HPLC) |
1884220-36-3 |
25mg |
¥136000 |
2024-03-01 |
購入 |
SBI-0206965 化学特性,用途語,生産方法
説明
ULK1 is a serine/threonine kinase that acts upstream of phosphatidylinositol 3-kinase (PI3K) to regulate the formation of autophagophores, the precursors of autophagosomes, in response to nutrient deprivation. It is activated by phosphorylation by AMPK and, in turn, phosphorylates and inhibits AMPK. SBI-0206965 is an inhibitor of ULK1 (IC
50 = 108 nM) that is less effective against ULK2 (IC
50 = 711 nM). It is selective for ULK1 and ULK2 over a panel of 456 additional kinases, showing activity against a few kinases
in vitro but not in cells. SBI-0206965 suppresses autophagy induced by mTOR inhibition
via AZD 8055 . It also blocks ULK1-dependent cell survival following nutrient deprivation.
使用
SBI-0206965 is an inhibitor of ULK1. It also blocks ULK1-dependent cell survival following nutrient deprivation. ULK1 is a serine/threonine kinase that acts upstream of phosphatidylinositol 3-kinase (PI3K) to regulate the formation of autophagophores, the precursors of autophagosomes, in response to nutrient deprivation.
Biochem/physiol Actions
Since most of the tumor cells survive on autophagy mechanism, inhibition of autophagy inducers Unc-51 (serine/threonine-protein kinase)-like autophagy activating kinase (ULK1 and ULK2) might be useful in cancer therapy.
SBI-0206965 上流と下流の製品情報
原材料
準備製品
SBI-0206965 生産企業
Global( 85)Suppliers
1884220-36-3()キーワード:
インテピルジン
イナリギビルソプロキシル
SB265610
N-[[(2S)-1-[2-メチル-5-(4-フルオロフェニル)-4-チアゾリルカルボニル]-2-ピペリジル]メチル]ベンゾフラン-4-カルボアミド
SB203580
SB-204741
マンザミンA
N-[4-(ピリジン-4-イル)チアゾール-2-イル]-3-メチルアニリン
(1S)-1,6bβ,7,8,9a,10,11,11b-オクタヒドロ-11β-アセチルオキシ-1-(メトキシメチル)-9aα,11bα-ジメチル-3H-フロ[4,3,2-de]インデノ[4,5-h]-2-ベンゾピラン-3,6,9-トリオン
キサントフモール
- 1884220-36-3
- SBI-0206965
- SBI0206965; SBI-0206965; SBI 0206965.
- Benzamide, 2-[[5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]oxy]-N-methyl-
- SBI-0206965(02)
- 2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide
- SBI 0206965;SBI0206965
- CS-1581
- SBI-0206965,SBI 0206965,inhibit,Inhibitor,Unc-51 like kinase,Apoptosis,Autophagy,ULK